Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Mehta

Showing results (291-300 of 299) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 299 results.
JAMA Surgery|May 5, 2021
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular CarcinomaKarim J Halazun, Russell E Rosenblatt, Neil Mehta, et al.
Annals of Surgery|July 31, 2023
Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American ExperienceTommy Ivanics, Marco P A W Claasen, Benjamin Samstein, et al.
Hepatology Communications|March 7, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter studyAmit G Singal, T Tara Ghaziani, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United StatesNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Pageof 30

Showing results (291-300 of 299) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 299 results.
JAMA Surgery|May 5, 2021
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular CarcinomaKarim J Halazun, Russell E Rosenblatt, Neil Mehta, et al.
Annals of Surgery|July 31, 2023
Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American ExperienceTommy Ivanics, Marco P A W Claasen, Benjamin Samstein, et al.
Hepatology Communications|March 7, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter studyAmit G Singal, T Tara Ghaziani, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United StatesNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Pageof 30